DFX Intelligence
Venture Capital Intelligence
Firms, funds, partners, companies and rounds from sworn filings, firm sites and announcements, kept as a graph with a date and a source on every edge. Facts, inferences and estimates are labelled as such. A fund target is never a close, GAV is never dry powder, and a round size is never an investor’s check.
Firms / OFP V Advisor Ab
OFP V Advisor Ab
One of 5 advisers that share ofco.se; the firm is HealthCap. Healthcap Advisor Ab, Healthcap Ix Advisor Ab, Healthcap VII Advisor Ab, Healthcap Viii Advisor Ab. Each keeps its own CRD, funds and filings; the grouping is the website each swore to on Form ADV and is recomputed every pass.
HealthCap, a life science investor and company creator. Our motivation is to find innovative ideas and invest that could impact healthcare and society.
venture manager, reported GAV $117M across 1 vehicles
Importance
39
elevated
Active deployment
30
moderate
Emerging
0
low
Completeness
63
high
Freshness
100
high
Research priority
15
moderate
Identity and regulatory footprint
- Headquarters
- Stockholm, Swedenadviserinfo.sec.gov
- Office address
- ENGELBREKSPLAN 1 4 STAIRS, Stockholm, 11434adviserinfo.sec.gov
- Business phone
- +46 8 4425850adviserinfo.sec.gov
- Website
- https://www.ofco.se
- SEC adviser type
- exempt reporting adviseradviserinfo.sec.gov
- SEC exemption claimed
- private fund adviseradviserinfo.sec.gov
- Latest Form ADV
- May 13, 2024
- Private funds reported
- 1 (1 venture capital funds)adviserinfo.sec.gov
- Private fund gross assets
- $117Madviserinfo.sec.govreported GAV of the funds, the adviser's own number; not fund size, not dry powder
- Owners on Schedule A
- Ibid Ab (Owner), A; Lindhold Ab (Owner), A; Amberjack Ab (Owner), A; Sorille Sa (Owner), B; Douvelle Ab (Owner), C; Cantando Ab (Owner), A; Healthback Ab (Shareholder), A
- business email
- carl.kilander@healthcap.euhealthcap.eupublished by the subject
- business email
- tyra.kuller@healthcap.euhealthcap.eupublished by the subject
- business phone
- +46 8 4425850adviserinfo.sec.govpublished by the subject
Stated thesis versus observed behaviour
38 observed deals
Stated (the firm’s website)
- Sectors
- healthcare, biotech, climate, media
- Stages
- not stated or not yet read
- Geography
- global, globally
- Check size
- not stated; DFX does not estimate checks from round sizes
- Self-described
- venture capital
Observed (from deals on record)
Stage at participation: no observed deals yet
Stage at first entry: no observed deals yet
Sectors
unknown 92%Biotechnology 8%
lead rate n/afollow-on rate n/anew logos, 12 months 38
Funds and vehicles
1 reported
| Vehicle | Type | Vintage | Lifecycle | Reported GAV | Owners | Form D sold | Latest Form D |
|---|---|---|---|---|---|---|---|
| Healthcap V LP | Fund | unknown | Unknown | $117M May 13, 2024 | 22 | unknown | unknown |
GAV is the gross asset value the adviser reported on Form ADV for the vehicle, never the fund’s committed size and never dry powder. Form D sold is the amount sold as of the latest filing, never a final close.
Investment team
32 current, 1 departed
Josefine Persson
AssociateAssociate | MSc
Nikolai Paus
AssociateAssociate I BSc
Nima Barati
AssociateMedical Associate I MD
Shamim Dadvar
AssociateAssociate | MD PhD
Thomas Ramdahl
General partnerDirector, GP | MSc PhD
Vanessa Malier
General partnerDirector, GP | MSc
Sofie Wennerqvist
OtherInvestment Monitor
Alex Valcu
PartnerPartner | MSc
Anki Forsberg
PartnerPartner and Chairman | LLM MBA
ANN Christine Forsberg
PartnerOwner · since May 1, 2006
Bjorn Odlander
PartnerOwner · since Mar 1, 2014
Carl Kilander
PartnerPartner | MD PhD
Daniel Karsberg
PartnerPartner | MSc
Fabrice Bernhard
PartnerGeneral Manager | MSc
Johan Christenson
PartnerOwner · since May 1, 2006
Johan Christenson
PartnerPartner | MD PhD
Kristina Ekberg
PartnerPartner | LLM
Max Odlander
PartnerPartner | MSc
Peder Fredrikson
PartnerOwner · since May 1, 2006
PER Johan Ture Samuelsson
PartnerOwner · since May 1, 2006
Per Samuelsson
PartnerPartner | MSc
Staffan Lindstrand
PartnerPartner | MSc
Staffan Lindstrand
PartnerOwner · since May 1, 2006
Marile Schiess
Platform and operationsHead of Compliance I MSc
Nattiya Simmano
Platform and operationsOffice Manager
Kristina Ekberg
PrincipalDirector · since Jun 1, 2022
Marten Steen
PrincipalDirector · since Jun 1, 2022
Oern R. Stuge
PrincipalDirector I MD MBA
PER Olof Eriksson
PrincipalDirector · since May 1, 2006
Carl-Johan Dalsgaard
Venture partnerVenture Partner | MD PhD
Eugen Steiner
Venture partnerVenture Partner | MD PhD
Georg Vo Beiske
Venture partnerVenture Partner | MSc
1 departed (kept with end dates)
- Jacob Gunterberg · Owner · May 1, 2006 to Apr 10, 2023 Inference
Investments on record
38 edges, 38 companies, 0 partner-attributed
“This investor” is the amount disclosed for this investor alone; it is unknown unless a source said it. The round size is the whole round.
Co-investors
18 relationships from shared deals, counted for the whole firm
Mitsui & Co. Global Investment, Inc. 1 shared · one timeBiogeneration III Services B.V. 1 shared · one timeOmega Fund Management, LLC 1 shared · one timeAsset Management Ventures, LLC 1 shared · one timeSofinnova Investments, Inc. 1 shared · one timeHBM Healthcare Investments 1 shared · one timeGrdnt LLC 1 shared · one timeAvoro Capital Advisors LLC 1 shared · one timeCrane Venture Partners LLP 1 shared · one timeLifeline Ventures 1 shared · one time · we led 1Sandwater 1 shared · one time · they led 1 · we led 1Deep Track Capital 1 shared · one timeSofinnova Partners 1 shared · one time · they led 1Maj Invest Equity 1 shared · one timeNovo Holdings 1 shared · one timeInvus 1 shared · one timeAccess Biotechnology 1 shared · one timeAvoro Ventures 1 shared · one time
Limited partners
0 disclosed
No LP commitment on record. An LP edge needs a public disclosure with a quote: a pension report (see Limited partners for the plans read), a fund announcement naming the LP, or a Form ADV owner. The fund page carries the LP’s reported performance.
Timeline
12 dated events
- Sep 16, 2026Howtogetridofwartshome no longer listed on OFP V Advisor Ab's portfolio pageRemoved from portfolio pagePortfolioInferenceHowtogetridofwartshomeVenture organization websites (about, team, portfolio, thesis, news pages)
- Sep 16, 2026myelodysplastic syndrome no longer listed on OFP V Advisor Ab's portfolio pageRemoved from portfolio pagePortfolioInferencemyelodysplastic syndromeVenture organization websites (about, team, portfolio, thesis, news pages)
- Sep 16, 2026anthracycline extravasation no longer listed on OFP V Advisor Ab's portfolio pageRemoved from portfolio pagePortfolioInferenceanthracycline extravasationVenture organization websites (about, team, portfolio, thesis, news pages)
- Sep 16, 2026heparin-induced thrombocytopenia no longer listed on OFP V Advisor Ab's portfolio pageRemoved from portfolio pagePortfolioInferenceheparin-induced thrombocytopeniaVenture organization websites (about, team, portfolio, thesis, news pages)
- Sep 16, 2026pulmonary embolism no longer listed on OFP V Advisor Ab's portfolio pageRemoved from portfolio pagePortfolioInferencepulmonary embolismVenture organization websites (about, team, portfolio, thesis, news pages)
- Sep 16, 2026deep vein thrombosis no longer listed on OFP V Advisor Ab's portfolio pageRemoved from portfolio pagePortfolioInferencedeep vein thrombosisVenture organization websites (about, team, portfolio, thesis, news pages)
- Sep 16, 2026low molecular weight heparin no longer listed on OFP V Advisor Ab's portfolio pageRemoved from portfolio pagePortfolioInferencelow molecular weight heparinVenture organization websites (about, team, portfolio, thesis, news pages)
- Apr 10, 2023Jacob Gunterberg (Owner) no longer on Schedule A of OFP V Advisor Ab
- Jun 1, 2022Kristina Ekberg joined Schedule A of OFP V Advisor Ab as Director
- Jun 1, 2022Marten Steen joined Schedule A of OFP V Advisor Ab as Director
- Jul 15, 2019OFP V Advisor Ab first filed Form ADV (ERA)First SEC adviser filingOrganizationFactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
- Jul 15, 2019Healthcap V LP first reported on Form ADV by OFP V Advisor Ab (Venture Capital Fund), GAV $48,628,823Fund first reported on Form ADVFundsFactHealthcap V LPSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Classification history
- Sep 12, 2026Institutional venture firm (probable, 80%, cls-1)venture manager, reported GAV $117M across 1 vehicles
Evidence
37 observations from 2 sources